The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma (Q34747431)

4 August 2017

title

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. (English)

1 reference

4 August 2017

1 reference

Michael J Barry

1 reference

4 August 2017

Floyd J Fowler

1 reference

4 August 2017

Mary McNaughton Collins

series ordinal

1 reference

4 August 2017

Elizabeth Walker Corkery

series ordinal

1 reference

4 August 2017

Diana B Elliott

series ordinal

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

1 reference

inferred from page(s)

published in

Cancer

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

287-295

1 reference

STUDIES ON PROSTATIC CANCER

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Patient-re ported complications and follow-up treatment after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Dimensions of quality of life expressed by men treated for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Early androgen deprivation for prostate cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

A brief male sexual function inventory for urology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10656

7 January 2021

Identifiers

DOI

10.1002/CNCR.10656

1 reference

release_ygumkyoprbfgvojwauub3lzhae

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ygumkyoprbfgvojwauub3lzhae

24 November 2022

mapped directly with Wikidata item

1 reference